NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR™ Assay MRD Assay at AACR 2022
Press Release
Read More
NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D
Press Release
Read More
NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022
Press Release
Read More
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer
Literature
Read More
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung Cancer
Press Release
Read More
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
Literature
Read More